|
Research Management and Support
|
RMS ES 2018
|
$340,640,887
|
$108,000
|
N/A
|
National Institutes of Health
|
|
Center for Multiple Myeloma Nanotherapy
|
5U54CA199092-03
|
$2,224,884
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Molecular mechanism of bitter melon juice efficacy against pancreatic cancer.
|
5R01CA195708-04
|
$382,753
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Mapping cancer micro-environments for acute leukemia
|
5R01CA202025-02
|
$462,880
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Single-Cell Measurement of Lipid Signaling in Colorectal Cancer
|
5R01CA177993-04
|
$584,480
|
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
|
5R01CA198074-03
|
$378,171
|
|
ALLEN, BENJAMIN
|
UNIVERSITY OF MICHIGAN
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-04
|
$435,560
|
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Bitter Melon Component and Colon Cancer Prevention
|
5R01CA190291-04
|
$544,710
|
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
|
5UG1CA189863-05
|
$2,680,381
|
|
ANDERSON, DANIEL
|
HEALTHPARTNERS INSTITUTE
|
|
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
|
5U01CA179671-04
|
$303,172
|
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
LGBT Adults and Tobacco Stigma: A Qualitative Study
|
5R01CA190238-03
|
$455,448
|
|
ANTIN, TAMAR
|
PACIFIC INSTITUTE FOR RES AND EVALUATION
|
|
The role of the hippocampal-prefrontal network in cancer-related cognitive impairment; a multimodal cross sectional study
|
5F31CA210719-02
|
$38,129
|
|
APPLE, ALEXANDRA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
5R01CA196854-03
|
$610,389
|
|
ARMENIAN, SARO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting of Aberrant Signaling in Patient-Derived Colorectal Cancer Models
|
5K08CA175153-05
|
$173,340
|
|
ATREYA, CHLOE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
|
5R01CA187143-04
|
$456,456
|
|
BADR, HODA
|
BAYLOR COLLEGE OF MEDICINE
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$91,803
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$5,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$2,725
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$1,514
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$635
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-08
|
$343,388
|
|
BAKER, SHARYN
|
OHIO STATE UNIVERSITY
|
|
Obesity, related comorbidities, and breast cancer outcomes in African Americans
|
5R01CA185623-04
|
$1,327,573
|
|
BANDERA, ELISA
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Multi-Site Development & Evaluation of a Quantitative 3D Hyperpolarized C-13 MRI Clinical Prostate Cancer Exam
|
1R01CA211150-01A1
|
$657,613
|
|
BANKSON, JAMES
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer
|
5R01CA135354-07
|
$380,000
|
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Increasing HPV Vaccine Uptake in a Low Income Ethnic Minority Population
|
5R01CA154549-06
|
$375,733
|
|
BASTANI, ROSHAN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Training Program in Nervous System Tumors
|
5K12CA090354-17
|
$805,200
|
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Targeting Mucin and EGFR Axis in Pancreatic Cancer
|
5R01CA183459-04
|
$311,659
|
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119 02020
|
$592,688
|
$29,634
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Corn Farming Study
|
ZIA CP010119 02075
|
$20,212
|
$1,011
|
Beane Freeman, Laura
|
DCEG (NCI)
|
|
Real-time Tumor Localization and Guidance for Radiotherapy Using US and MRI
|
5R01CA190298-03
|
$632,258
|
|
BEDNARZ, BRYAN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Iowa-Wide Oncology Research Coalition (I-WORC)
|
5UG1CA189816-04
|
$1,030,000
|
|
BEHRENS, ROBERT
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
Radiobiology Outreach
|
ZIA CP010222 10441
|
$66,403
|
$13,281
|
Berrington, Amy
|
DCEG (NCI)
|
|
Pediatric CT Examinations in Israel
|
ZIA CP010222 10543
|
$66,403
|
$6,640
|
Berrington, Amy
|
DCEG (NCI)
|
|
Breaking the paradigm: RhoA as a tumor suppressor in cancer
|
1F31CA216965-01
|
$30,078
|
|
BLAKE, DEVON
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
SWOG NCORP Research Base
|
5UG1CA189974-04
|
$4,459,372
|
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Expanding the Reach of a Validated Smoking-Cessation Intervention: A Spanish-language RCT
|
5R01CA199143-02
|
$570,307
|
|
BRANDON, THOMAS
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
1/2 Addressing Rural Cancer Health Disparities: An SCC-SIUSM Partnership
|
5P20CA192987-03
|
$212,906
|
|
BRARD, LAURENT
|
SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
|
|
Biomarkers of human papillomavirus (HPV) infection and risk of two increasing cancers
|
5U01CA195603-03
|
$466,874
|
|
BRENNAN, PAUL
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
Molecular characterization of myeloma and related asymptomatic precursor states
|
5R01CA186646-04
|
$1,043,373
|
|
BROWN, ELIZABETH
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Optimization of a clinical stage nanoparticle drug delivery platform
|
5R44CA186410-03
|
$998,609
|
|
BROWN, BOB
|
DICERNA PHARMACEUTICALS, INC.
|
|
CHRONIC CONVECTION ENHANCED DELIVERY (CED) OF TOPOTECAN FOR GLIOBLASTOMA
|
5R01CA161404-06
|
$532,270
|
|
BRUCE, JEFFREY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
|
5P50CA196516-02
|
$2,300,000
|
|
BRUGAROLAS, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Quantitative Imaging to Assess Response in Cancer Therapy Trials
|
5U01CA140206-08
|
$622,467
|
|
BUATTI, JOHN
|
UNIVERSITY OF IOWA
|
|
The Dynamics of Smoking Cessation After Cancer Diagnosis: A Naturalisitic Study
|
5K07CA181351-04
|
$153,805
|
|
BURRIS, JESSICA
|
UNIVERSITY OF KENTUCKY
|
|
Resistance Training to Reduce Chemotoxicity in Colon Cancer
|
1R01CA206196-01A1
|
$870,094
|
|
CAAN, BETTE
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
Sedentary Behavior and Breast Cancer: Interventions and Biomarkers
|
5K07CA178870-04
|
$134,448
|
|
CADMUSBERTRAM, LISA
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
I-131 in childhood and thyroid cancer (Belarus)
|
ZIA CP010132 04019
|
$36,726
|
$36,726
|
Cahoon, Elizabeth
|
DCEG (NCI)
|
|
I-131 in childhood and thyroid cancer (Ukraine)
|
ZIA CP010132 04173
|
$59,169
|
$59,169
|
Cahoon, Elizabeth
|
DCEG (NCI)
|
|
I-131 in utero and thyroid disease (Ukraine)
|
ZIA CP010132 10661
|
$24,277
|
$24,277
|
Cahoon, Elizabeth
|
DCEG (NCI)
|
|
I-131 dose and risk of thyroid disease
|
ZIA CP010132 10785
|
$21,895
|
$21,895
|
Cahoon, Elizabeth
|
DCEG (NCI)
|
Total relevant funding to Thyroid for this search: $16,044,283
|